Profil
Jonathan Dole is the founder of Endpoint Clinical, Inc. which was founded in 2009.
He is currently working as a Director at Atreo, Inc. since 2023.
Aktive Positionen von Jonathan Dole
| Unternehmen | Position | Beginn |
|---|---|---|
Atreo, Inc.
 Atreo, Inc. Packaged SoftwareTechnology Services Atreo, Inc. offers modern testing practices for RTSM (Randomization and Trial Supply Management) that provide 10x testing coverage compared to legacy providers. The American company allows clients to preview their RTSM, tailored to their protocol, at bid defense and throughout the system design experience. Ryan Harrison has been the CEO of the company since 2021. | Direktor/Vorstandsmitglied | 19.07.2023 |
Ehemalige bekannte Positionen von Jonathan Dole
| Unternehmen | Position | Ende |
|---|---|---|
Endpoint Clinical, Inc.
 Endpoint Clinical, Inc. Information Technology ServicesTechnology Services LabCorp Endpoint Clinical, Inc. develops technology platform to support the life sciences industry. The firm have deployed systems to small, medium and large pharma for domestic and global studies. The company was founded by Jonathan Dole and Tom O’Connell in 2009 and is headquartered in San Francisco, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Endpoint Clinical, Inc.
Endpoint Clinical, Inc. Information Technology ServicesTechnology Services LabCorp Endpoint Clinical, Inc. develops technology platform to support the life sciences industry. The firm have deployed systems to small, medium and large pharma for domestic and global studies. The company was founded by Jonathan Dole and Tom O’Connell in 2009 and is headquartered in San Francisco, CA. | Technology Services |
Atreo, Inc.
Atreo, Inc. Packaged SoftwareTechnology Services Atreo, Inc. offers modern testing practices for RTSM (Randomization and Trial Supply Management) that provide 10x testing coverage compared to legacy providers. The American company allows clients to preview their RTSM, tailored to their protocol, at bid defense and throughout the system design experience. Ryan Harrison has been the CEO of the company since 2021. | Technology Services |
